share_log

HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $54 Price Target

Benzinga ·  Mar 17, 2023 18:45

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Buy and maintains $54 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment